U.S., March 27 -- ClinicalTrials.gov registry received information related to the study (NCT06895564) titled 'Proton SBRT for Spinal Metastasis' on March 19.
Brief Summary: This is a single-arm pilot study of proton stereotactic body radiotherapy (SBRT) for nonhematologic spinal metastasis in patients with complex lesions that are unable to be effectively treated with standard of care photon SBRT defined as inability to develop a photon SBRT plan that achieves adequate coverage (>=80% planning treatment volume (PTV) coverage)) with a prescription dose of 30 Gy in 5 fractions.
Study Start Date: April, 2025
Study Type: INTERVENTIONAL
Condition:
Spinal Metastasis
Intervention:
RADIATION: Spinal Proton SBRT
Patients will be treated with...